UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites
29 January 2026
1 min read

UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

New York, Jan 29, 2026, 10:22 EST — Regular session

Shares of UnitedHealth Group Incorporated (UNH.N) dropped 1.2% to $290.50 by 10:07 a.m. EST Thursday, marking another volatile day for the U.S. health insurance giant this week.

The stock has swung sharply after regulators unveiled a near-flat update for 2027 Medicare Advantage rates — the payments the government makes to private Medicare plans serving seniors and people with disabilities. The Centers for Medicare and Medicaid Services suggested a 0.09% increase, far below the expected rise of up to 6%. Analysts warn insurers might have to trim benefits or withdraw from plans if these figures hold. 1

UnitedHealth on Tuesday flagged strong execution and a 2026 outlook that projects revenue topping $439 billion alongside adjusted earnings exceeding $17.75 per share, following 2025 revenue of $447.6 billion. CEO Stephen Hemsley said the company closed out 2025 “as a much stronger company,” despite a challenging year. 2

Investors zeroed in on the policy squeeze. UnitedHealth tumbled as much as 19% Tuesday, closing at $282.45—its steepest one-day fall since April last year. The drop followed CEO Tim Noel’s comments on the Medicare proposal, which he called “disappointing,” warning it will force “very meaningful benefit reductions” and a closer look at the company’s footprint. The firm also projected a 2026 medical care ratio of roughly 88.8%, the portion of premiums spent on care. Additionally, UnitedHealth took a $1.6 billion after-tax charge linked to the Change Healthcare cyberattack and restructuring. 3

Wall Street began dialing back expectations. Oppenheimer’s Michael Wiederhorn lowered his price target to $385 from $415, maintaining an “outperform” rating. He cited robust results at UnitedHealthcare but noted weakness at Optum amid ongoing restructuring. 4

The obvious downside: if reimbursement remains tight and medical costs keep climbing, insurers might have to take measures that slow growth before margins improve. Policy risk is tough to manage—one change in the final rate notice can wipe out a year’s projections.

Other managed-care stocks held steady early on: Humana barely moved, CVS Health ticked up slightly, and Cigna edged down a bit.

The next major event is on the government’s schedule. CMS will release the final 2027 Medicare Advantage rate announcement by April 6, with public comments expected by Feb. 25. 5

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Broadcom (AVGO) stock price drops nearly 2% as chip shares slide ahead of Apple earnings
Previous Story

Broadcom (AVGO) stock price drops nearly 2% as chip shares slide ahead of Apple earnings

XRP price slips near $1.80 as Fed pause and Ripple headlines jolt the token — what’s next
Next Story

XRP price slips near $1.80 as Fed pause and Ripple headlines jolt the token — what’s next

Go toTop